Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,126 public trials 2,032 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, not recruiting

Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)

NCT04268706

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Disease Recurrent, +10 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details
Active, not recruiting

Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma

NCT02544308

Conditions
Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, +4 more
Locations
  • Royal United Hospital Bath, United Kingdom
  • Blackpool Victoria Hospital Blackpool, United Kingdom
  • University Hospital Wales Cardiff, United Kingdom
  • Velindre Cancer Centre Cardiff, United Kingdom
View all 13 locations
View Trial Details
Active, not recruiting

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

NCT01744223

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +16 more
Locations
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University Hospitals of Cleveland Cleveland, Ohio, United States
View Trial Details
Active, not recruiting

Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant

NCT03301168

Conditions
Acute Lymphoblastic Leukemia, Anemia, Anemia, Aplastic, +34 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
View Trial Details
Active, not recruiting

Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant

NCT02477878

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
Locations
  • BMT Program at Northside Hospital Atlanta, Georgia, United States
  • University of Kansas Westwood, Kansas, United States
  • Roswell Park Buffalo, New York, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details

Related conditions